Apimeds Pharmaceuticals US, Inc. (APUS) › Shares OutstandingApimeds Pharmaceuticals US, Inc. (APUS) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2023: 7.90M2024: 7.90M2025: 12.58M12.58M2023Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202512.58M+59.1%20247.90M+0.0%20237.90M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share